Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Artiva Biotherapeutics, Inc. (ARTV) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Artiva Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1817241.
Total stock buying since 2024: $256,499,936.
Total stock sales since 2024: $741,015.
Total stock option exercises since 2024: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 7,942,707 | $91,499,984 | 53,040 | $477,782 | 0 | $0 |
| 2025 | 0 | $0 | 60,562 | $263,233 | 0 | $0 |
| 2024 | 13,749,996 | $164,999,952 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-05 | 7,942,707 | $91,499,984 | 53,040 | $477,782 | 0 | $0 |
| 2025-12 | 0 | $0 | 3,187 | $19,122 | 0 | $0 |
| 2025-11 | 0 | $0 | 6,375 | $21,522 | 0 | $0 |
| 2025-10 | 0 | $0 | 25,500 | $153,000 | 0 | $0 |
| 2025-08 | 0 | $0 | 25,500 | $69,589 | 0 | $0 |
| 2024-07 | 13,749,996 | $164,999,952 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-19 | Banerjee Subhashis (Chief Medical Officer) | Sale | 7,037 | 9.01 | 63,389 |
| 2026-05-19 | Raymon Heather (SVP, Research and Development) | Sale | 3,095 | 9.01 | 27,879 |
| 2026-05-19 | Aslan Fred (Chief Executive Officer) | Sale | 27,116 | 9.01 | 244,260 |
| 2026-05-19 | Horan Christopher (Chief Tech Operations Officer) | Sale | 7,002 | 9.01 | 63,074 |
| 2026-05-19 | Bush Jennifer (COO, CLO, Compliance Officer) | Sale | 8,790 | 9.01 | 79,180 |
| 2026-05-11 | Gc Cell Corp | Buy | 1,432,291 | 11.52 | 16,499,992 |
| 2026-05-11 | Shah Rajeev M. | Buy | 6,510,416 | 11.52 | 74,999,992 |
| 2025-12-15 | Aslan Fred (President and CEO) | Sale | 3,187 | 6.00 | 19,122 |
| 2025-11-17 | Aslan Fred (President and CEO) | Sale | 6,375 | 3.38 | 21,522 |
| 2025-10-17 | Aslan Fred (President and CEO) | Sale | 25,500 | 6.00 | 153,000 |
| 2025-08-15 | Aslan Fred (President and CEO) | Sale | 25,500 | 2.73 | 69,589 |
| 2024-07-22 | Gc Cell Corp | Buy | 2,083,332 | 12.00 | 24,999,984 |
| 2024-07-22 | Huh Yong-jun | Buy | 2,083,332 | 12.00 | 24,999,984 |
| 2024-07-22 | Shah Rajeev M. | Buy | 8,333,333 | 12.00 | 99,999,996 |
| 2024-07-22 | Schwab Andrew J. | Buy | 833,333 | 12.00 | 9,999,996 |
| 2024-07-22 | Goodman Corey S | Buy | 416,666 | 12.00 | 4,999,992 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARTV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Artiva Biotherapeutics, Inc. (symbol ARTV, CIK number 1817241) see the Securities and Exchange Commission (SEC) website.